NEW YORK, May 25 (GenomeWeb News) - Invitrogen, with two acquisitions already under its belt this year, has done it again.

The Carlsbad, Calif.-based company has purchased the assets of microarray maker Xeotron of Houston, Texas, for an undisclosed sum, the company confirmed today.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.